Metformin Treatment Before in Vitro Fertilization (IVF) in Women With Ultrasound Evidence of Polycystic Ovaries

NACompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Metformin

Women were randomised to receive either metformin or placebo starting three weeks before initiation of a GnRH agonist during an IVF treatment cycle (seven weeks prior to oocyte collection and then stopped at oocyte collection). Seventy identical packs of metformin and 70 identical packs of placebo were supplied by DHP Ltd, Crickhowell, Powys (UK) a commercial clinical trial supplier. The randomisation service was provided by DHP Ltd.

DRUG

Placebo

Women were randomised to receive either metformin or placebo starting three weeks before initiation of a GnRH agonist during an IVF treatment cycle (seven weeks prior to oocyte collection and then stopped at oocyte collection). Seventy identical packs of metformin and 70 identical packs of placebo were supplied by DHP Ltd, Crickhowell, Powys (UK) a commercial clinical trial supplier. The randomisation service was provided by DHP Ltd.

Trial Locations (3)

Unknown

IVF Hammersmith, London

Nuture IVF Unit, Nottingham

OX39DU

Oxford Fertility Unit, Oxford

All Listed Sponsors
collaborator

Imperial College London

OTHER

collaborator

University of Nottingham

OTHER

lead

University of Oxford

OTHER

NCT01046032 - Metformin Treatment Before in Vitro Fertilization (IVF) in Women With Ultrasound Evidence of Polycystic Ovaries | Biotech Hunter | Biotech Hunter